1. At a Glance – The Smell of Chemicals… or Trouble?
There’s something beautifully ironic about a company that manufactures pesticides… slowly poisoning its own balance sheet.
Heranba Industries — once marketed as India’s rising agrochemical champion — is now sitting with ₹1,610 crore revenue but a negative ₹60 crore PAT, margins thinner than your Wi-Fi signal during IPL streaming, and a balance sheet that looks like it just survived a chemical explosion.
Add to that:
- Debt has ballooned to ₹513 crore
- Interest coverage? A spicy 0.13
- IBC filings already knocking at the door (yes, real ones, not Twitter rumours)
- And management casually calling FY25 a “transitionary year” (translation: “please don’t panic… yet”)
Meanwhile, management is promising ₹1,850–1,950 crore revenue and 12–14% EBITDA margins in FY26 like a politician promising pothole-free roads before elections.
So the real question is:
👉 Is this a temporary industry downturn… or a textbook case of over-expansion gone wrong?
Let’s investigate like a slightly suspicious auditor who has seen too many “turnaround stories.”
2. Introduction – The Rise, The CAPEX, The Reality Check
Heranba Industries entered the agrochemical scene in 1994, quietly building a strong portfolio of insecticides, herbicides, and fungicides.
Then came the big dream:
👉 Become a global agrochemical powerhouse.
And how do you do that in India?
Simple:
- Raise capital
- Build massive plants
- Talk about China+1
- Mention “exports” 17 times in every concall
Boom. Investor excitement unlocked.
But reality had other plans.
By FY25:
- Global agrochemical demand slowed
- Inventory piled up worldwide
- Prices of technicals (core products) crashed
- New plants started… but at low utilization
Management literally said:
“Pricing is at the bottom… everyone is suffering.”
That’s not guidance. That’s a cry for help.
And yet… revenue is growing.
Which brings us to the classic Indian midcap paradox:
👉 “Sales up, profits down, debt up — kya ho raha hai bhai?”
3. Business Model – WTF Do They Even Do?
Let’s simplify Heranba’s business like you’re explaining it to your cousin who thinks stock market = IPL betting.
Three-layer model:
1. Intermediates
Basic chemicals used internally
(Think: ingredients before cooking)
2. Technicals
Core pesticide molecules
(Think: the main dish)
3. Formulations
Ready-to-use products for farmers
(Think: packaged biryani)
Revenue mix shift (important plot twist):
- Technicals: 67% → 50%
- Formulations: 33% → 50%
This shift is intentional.
Why?
Because formulations = higher margins.
But here’s the twist:
👉 Technical prices crashed globally
👉 So the mix shift is partly strategy… partly compulsion
Customer base?
Big names:
- UPL
- PI Industries
- Sumitomo
- Rallis
So demand is not the issue.
The issue is:
👉 Pricing + utilization + cost structure
Capacity obsession
Heranba has:
